Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Hydrogels could lead to better treatments for wound healing without scars.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Fat cells are important for tissue repair and stem cell support in various body parts.

Aging slows wound healing due to weaker cells and immune response.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Hair loss requires customized treatments based on its various causes and types.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Soy isoflavones can protect lung tissue from radiation damage.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Fat stem cells from diabetic mice can still help heal wounds.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.